{"id":149886,"date":"2026-07-14T15:07:24","date_gmt":"2026-07-14T09:37:24","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=149886"},"modified":"2026-07-14T15:07:25","modified_gmt":"2026-07-14T09:37:25","slug":"vivo-bio-tech-q1-results-fy27-pat-0-19-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/","title":{"rendered":"Vivo Bio Tech Q1 Results FY27: PAT Falls 85.97% Despite Revenue Growth of 14.13%"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Vivo Bio Tech Q1 FY27: PAT Rs 0.19 Cr, down 85.97% YoY. Revenue Rs 14 Cr, up 14.13%. Gross profit Rs 1 Cr, down 46.55%. Stock at Rs 24.15, down 4.13% on 13 July 2026.<\/em><\/p>\n<p>Vivo Bio Tech Q1 results FY27 were announced on Monday, 13 July 2026, with the Hyderabad based drug development and preclinical research services company reporting a standalone net profit of Rs 0.19 crore, down 85.97% from Rs 1 crore in the year ago quarter. Revenue in the Vivo Bio Tech Q1 results FY27 grew 14.13% year on year to Rs 14 crore from Rs 12 crore, even as gross profit fell 46.55% to around Rs 1 crore.<\/p>\n<p>Shares of <a href=\"https:\/\/univest.in\/stocks\/vivobiot\/vivo-bio-tech-ltd-share-price-today\">Vivo Bio Tech<\/a> fell 4.13% to close at Rs 24.15, with the market reacting to the sharp profit decline despite the healthy revenue growth, a disconnect that points to significant margin pressure during the quarter.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=vivo-bio-tech-q1-fy27-pat\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#Vivo_Bio_Tech_Q1_results_FY27_Financial_Highlights\" title=\"Vivo Bio Tech Q1 results FY27 Financial Highlights\">Vivo Bio Tech Q1 results FY27 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#Vivo_Bio_Tech_Q1_results_FY27_Performance_Analysis\" title=\"Vivo Bio Tech Q1 results FY27 Performance Analysis\">Vivo Bio Tech Q1 results FY27 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#Vivo_Bio_Tech_Q1_results_FY27_Key_Business_Factors\" title=\"Vivo Bio Tech Q1 results FY27: Key Business Factors\">Vivo Bio Tech Q1 results FY27: Key Business Factors<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#1_Contract_Research_Business_Model\" title=\"1. Contract Research Business Model\">1. Contract Research Business Model<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#2_Rising_Operating_Costs\" title=\"2. Rising Operating Costs\">2. Rising Operating Costs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#3_Historical_Profit_Volatility\" title=\"3. Historical Profit Volatility\">3. Historical Profit Volatility<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#Dividend_Details\" title=\"Dividend Details\">Dividend Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#Vivo_Bio_Tech_Q1_results_FY27_Outlook_for_the_Full_Year\" title=\"Vivo Bio Tech Q1 results FY27 Outlook for the Full Year\">Vivo Bio Tech Q1 results FY27 Outlook for the Full Year<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#Vivo_Bio_Tech_Stock_Performance_After_the_Q1_Results\" title=\"Vivo Bio Tech Stock Performance After the Q1 Results\">Vivo Bio Tech Stock Performance After the Q1 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#Key_Risks\" title=\"Key Risks\">Key Risks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#1_Volatile_Quarterly_Profitability\" title=\"1. Volatile Quarterly Profitability\">1. Volatile Quarterly Profitability<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#2_Niche_Relationship-Dependent_Business\" title=\"2. Niche, Relationship-Dependent Business\">2. Niche, Relationship-Dependent Business<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#3_Small_Cap_Liquidity_and_Governance\" title=\"3. Small Cap Liquidity and Governance\">3. Small Cap Liquidity and Governance<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#Frequently_Asked_Questions_on_Vivo_Bio_Tech_Q1_results_FY27\" title=\"Frequently Asked Questions on Vivo Bio Tech Q1 results FY27\">Frequently Asked Questions on Vivo Bio Tech Q1 results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#When_were_the_Vivo_Bio_Tech_Q1_results_FY27_announced\" title=\"When were the Vivo Bio Tech Q1 results FY27 announced?\">When were the Vivo Bio Tech Q1 results FY27 announced?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#What_is_the_PAT_in_Vivo_Bio_Tech_Q1_results_FY27\" title=\"What is the PAT in Vivo Bio Tech Q1 results FY27?\">What is the PAT in Vivo Bio Tech Q1 results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#What_was_the_revenue_in_Vivo_Bio_Tech_Q1_results_FY27\" title=\"What was the revenue in Vivo Bio Tech Q1 results FY27?\">What was the revenue in Vivo Bio Tech Q1 results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#Why_did_Vivo_Bio_Tech_profit_fall_despite_revenue_growth_in_Q1_FY27\" title=\"Why did Vivo Bio Tech profit fall despite revenue growth in Q1 FY27?\">Why did Vivo Bio Tech profit fall despite revenue growth in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#What_does_Vivo_Bio_Tech_do_as_a_company\" title=\"What does Vivo Bio Tech do as a company?\">What does Vivo Bio Tech do as a company?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#How_did_Vivo_Bio_Tech_share_price_react_to_the_Q1_results_FY27\" title=\"How did Vivo Bio Tech share price react to the Q1 results FY27?\">How did Vivo Bio Tech share price react to the Q1 results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/vivo-bio-tech-q1-results-fy27-pat-0-19-crore\/#Is_Vivo_Bio_Tech_a_good_buy_after_the_Q1_results_FY27\" title=\"Is Vivo Bio Tech a good buy after the Q1 results FY27?\">Is Vivo Bio Tech a good buy after the Q1 results FY27?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Vivo_Bio_Tech_Q1_results_FY27_Financial_Highlights\"><\/span><strong>Vivo Bio Tech Q1 results FY27 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The June quarter showed revenue growth alongside a sharp profit collapse, a combination that defines the Vivo Bio Tech Q1 results FY27. The table below summarises the standalone numbers against the year ago quarter, in rounded crore terms.<\/p>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Q1 FY27<\/th>\n<th>Q1 FY26<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Revenue<\/td>\n<td>Rs 14 Cr<\/td>\n<td>Rs 12 Cr<\/td>\n<td>+14.13%<\/td>\n<\/tr>\n<tr>\n<td>Gross Profit<\/td>\n<td>Rs 1 Cr<\/td>\n<td>Rs 2 Cr<\/td>\n<td>-46.55%<\/td>\n<\/tr>\n<tr>\n<td>Net Profit (PAT)<\/td>\n<td>Rs 0.19 Cr<\/td>\n<td>Rs 1 Cr<\/td>\n<td>-85.97%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The gap between healthy revenue growth and a sharp profit collapse in the Vivo Bio Tech Q1 results FY27 indicates the company&#8217;s cost base rose significantly faster than its top line, a pattern worth digging into further through the company&#8217;s detailed disclosures.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Vivo_Bio_Tech_Q1_results_FY27_Performance_Analysis\"><\/span><strong>Vivo Bio Tech Q1 results FY27 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Get Personalised Guidance from a SEBI-Registered Investment Advisor<\/strong><\/a><\/p>\n<p>The most striking feature of the Vivo Bio Tech Q1 results FY27 is that revenue grew a healthy 14.13% even as PAT collapsed 85.97%, a divergence that points to a sharp rise in operating costs, possibly linked to lab operations, animal husbandry costs, or investment in research capacity that has not yet translated into proportional revenue.<\/p>\n<p>Vivo Bio Tech provides drug development and discovery services including toxicity studies, pharmacological investigations, and preclinical research to pharmaceutical and biotech clients globally, alongside supplying laboratory animal models. This is a specialised, relatively niche contract research business where quarterly profitability has historically shown some volatility.<\/p>\n<p>Historical data shows Vivo Bio Tech&#8217;s profit has fluctuated significantly across past quarters, so investors reading the Vivo Bio Tech Q1 results FY27 should view this as part of a longer pattern of volatility in this small cap contract research organisation rather than necessarily a one-off event.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Vivo_Bio_Tech_Q1_results_FY27_Key_Business_Factors\"><\/span><strong>Vivo Bio Tech Q1 results FY27: Key Business Factors<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_Contract_Research_Business_Model\"><\/span><strong>1. Contract Research Business Model<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As a preclinical contract research organisation, revenue in the Vivo Bio Tech Q1 results FY27 depends on winning and executing study contracts for pharmaceutical and biotech clients, a business where costs can rise ahead of revenue recognition on new projects.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Rising_Operating_Costs\"><\/span><strong>2. Rising Operating Costs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The sharp gap between revenue growth and profit decline suggests operating costs, potentially including lab animal care, research staff, or facility expenses, grew significantly faster than revenue during the quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Historical_Profit_Volatility\"><\/span><strong>3. Historical Profit Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Company disclosures over past years show a pattern of swinging quarterly profitability, meaning the sharp decline in the Vivo Bio Tech Q1 results FY27 fits a broader pattern rather than representing an entirely new trend for this business.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dividend_Details\"><\/span><strong>Dividend Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No dividend was announced along with the Vivo Bio Tech Q1 results FY27. Given the sharp profit decline and the small scale of the business, near-term capital priorities are likely focused on managing costs rather than shareholder payouts.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Vivo_Bio_Tech_Q1_results_FY27_Outlook_for_the_Full_Year\"><\/span><strong>Vivo Bio Tech Q1 results FY27 Outlook for the Full Year<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Whether this quarter&#8217;s cost pressure eases in subsequent quarters will be the key factor to watch. Investors should track revenue growth trends in the core contract research business, any disclosed reasons for the margin compression, and whether profitability recovers toward levels seen in stronger recent quarters.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Vivo_Bio_Tech_Stock_Performance_After_the_Q1_Results\"><\/span><strong>Vivo Bio Tech Stock Performance After the Q1 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Vivo Bio Tech live share price and upcoming quarterly results.<\/em><\/p>\n<p>Vivo Bio Tech share price fell 4.13% to close at Rs 24.15 after the Vivo Bio Tech Q1 results FY27, reflecting market disappointment with the sharp profit decline despite the healthy revenue growth.<\/p>\n<p>As a small cap contract research stock with a history of volatile quarterly results, the counter can see sharp price swings on both positive and negative news, and investors should size positions with this volatility in mind.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks\"><\/span><strong>Key Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors going through the fine print of the Vivo Bio Tech Q1 results FY27 should also weigh the following risks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"1_Volatile_Quarterly_Profitability\"><\/span><strong>1. Volatile Quarterly Profitability<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As seen repeatedly in past quarters and again in the Vivo Bio Tech Q1 results FY27, profit at this company can swing sharply from one quarter to the next, making it difficult to extrapolate a single quarter&#8217;s trend.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Niche_Relationship-Dependent_Business\"><\/span><strong>2. Niche, Relationship-Dependent Business<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Contract research revenue depends on winning and retaining client relationships in a specialised, relatively small addressable market, with limited diversification compared with larger pharmaceutical services companies.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Small_Cap_Liquidity_and_Governance\"><\/span><strong>3. Small Cap Liquidity and Governance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As a small cap stock, investors should apply extra scrutiny to disclosures and governance practices, and expect limited trading liquidity typical of companies at this scale.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Vivo Bio Tech Q1 results FY27 show a sharp divergence, with revenue up a healthy 14.13% to Rs 14 crore even as PAT collapsed 85.97% to Rs 0.19 crore, reflecting significant cost pressure during the quarter. Revenue growth in the core contract research business is the lone bright spot in the Vivo Bio Tech Q1 results FY27, against a backdrop of volatile historical profitability. Investors should treat this as a high risk small cap and consult a SEBI-registered advisor before acting on the numbers.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Vivo_Bio_Tech_Q1_results_FY27\"><\/span><strong>Frequently Asked Questions on Vivo Bio Tech Q1 results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"When_were_the_Vivo_Bio_Tech_Q1_results_FY27_announced\"><\/span><strong>When were the Vivo Bio Tech Q1 results FY27 announced?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Vivo Bio Tech Q1 results FY27 were announced on Monday, 13 July 2026, for the quarter ended 30 June 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PAT_in_Vivo_Bio_Tech_Q1_results_FY27\"><\/span><strong>What is the PAT in Vivo Bio Tech Q1 results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The PAT in Vivo Bio Tech Q1 results FY27 fell 85.97% to Rs 0.19 crore from Rs 1 crore in Q1 FY26, despite healthy revenue growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_revenue_in_Vivo_Bio_Tech_Q1_results_FY27\"><\/span><strong>What was the revenue in Vivo Bio Tech Q1 results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue in the Vivo Bio Tech Q1 results FY27 grew 14.13% year on year to Rs 14 crore from Rs 12 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Vivo_Bio_Tech_profit_fall_despite_revenue_growth_in_Q1_FY27\"><\/span><strong>Why did Vivo Bio Tech profit fall despite revenue growth in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> PAT fell sharply in the Vivo Bio Tech Q1 results FY27 even as revenue grew 14.13%, suggesting operating costs, potentially tied to lab operations or research capacity, rose significantly faster than revenue during the quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Vivo_Bio_Tech_do_as_a_company\"><\/span><strong>What does Vivo Bio Tech do as a company?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Vivo Bio Tech is a Hyderabad based contract research organisation providing drug development, preclinical toxicity studies, pharmacological investigations and laboratory animal models to pharmaceutical and biotech clients.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Vivo_Bio_Tech_share_price_react_to_the_Q1_results_FY27\"><\/span><strong>How did Vivo Bio Tech share price react to the Q1 results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Vivo Bio Tech share price fell 4.13% to close at Rs 24.15 after the Vivo Bio Tech Q1 results FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Vivo_Bio_Tech_a_good_buy_after_the_Q1_results_FY27\"><\/span><strong>Is Vivo Bio Tech a good buy after the Q1 results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Vivo Bio Tech Q1 results FY27 show a sharp profit decline despite revenue growth, and the company has a history of volatile quarterly results. This article is for educational purposes only. Consult a SEBI-registered advisor before investing.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vivo Bio Tech Q1 results FY27: PAT collapses 85.97% despite revenue growth of 14.13% to Rs 14 crore. Full analysis of this Hyderabad based contract research organisation&#8217;s margin pressure.<\/p>\n","protected":false},"author":28,"featured_media":150752,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-149886","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1784021848:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["80"],"rank_math_title":["Vivo Bio Tech Q1 FY27: PAT Falls 86%, Revenue Up 14%"],"rank_math_description":["Vivo Bio Tech Q1 results FY27: PAT falls 85.97% YoY despite revenue growth of 14.13% to Rs 14 crore. Full Hyderabad based CRO Q1 FY27 results analysis."],"rank_math_focus_keyword":["Vivo Bio Tech Q1"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["150752"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["26139"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Vivo-Bio-Tech-Q1-Results.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/149886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=149886"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/149886\/revisions"}],"predecessor-version":[{"id":150753,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/149886\/revisions\/150753"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/150752"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=149886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=149886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=149886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}